Bioequivalence of a methylphenidate hydrochloride extended-release preparation: Comparison of an intact capsule and an opened capsule sprinkled on applesauce

International Journal of Clinical Pharmacology and Therapeutics

Volumn 44, Issue 3, 2006, Pages 135-141

  Fischer, R ^a   Schutz H ^b   Grossmann, M ^c   Leis, H J ^d   Ammer, R ^a  

^a Medice   (Germany)

^b BEBAC   (Austria)

^c IKP   (Germany)

^d BPA   (Austria)

Author keywords

ADHD; Bioequivalence; Food effect; Medikinet retard; Medikinet XL; Methylphenidate

Indexed keywords

MEDIKINET RETARD; METHYLPHENIDATE;

ABDOMINAL PAIN; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CAPSULE FILLING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; FATIGUE; FEMALE; FOOD DRUG INTERACTION; FOOD INTAKE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; PHOTOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SUSTAINED RELEASE FORMULATION;

EID: 33644785715     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP44135     Document Type: Article

References (13)

1. Blume H, Schug B, Tautz J, Erb K. New guidelines for the assessment of bioavailability and bioequivalence. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2005; 48: 548-555.
2. Döpfner M, Banaschewski T, Schmidt J, Uebel H, Schmeck K, Gerber WD, Günther M, Knölker M, Gehrke M, Hässler F, Möhler E, Brünger M, Ose C, Fischer R, Poustka F, Lehmkuhl G, Rothenberger A. Long-acting methylphenidate preparation in children with ADHD - a multicenter study. Nervenheilkunde. 2003; 22: 85-92.
3. Döpfner M, Gerber WD, Banaschewski T, Breuer D, Freisleder FJ, Gerber G, Günther M, Hässier F, Ose C, Rothenberger A, Schmeck K, Sinzig J, Stadler C, Uebel H, Lehmkuhl G. Comparative efficacy of once-a-day extended-release methylphenidate, two-times daily immediate-release methylphenidate, and placebo in a laboratory school setting. Eur Child Adolesc Psychiatry. 2004; 13 (Suppl 1): 193-1101.
4. European Medicines Agency. Reflection Paper: Formulations of Choice for the Paediatric Population. 2005; http://www.emea.eu.int/pdfs/human/peg/19481005en.pdf.
5. Hauschke D, Steinijans VW, Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol. 1990; 28: 72-78.
6. Leis HJ, Fauler G, Raspotnig G, Windischhofer W. Negative ion chemical ionization for the determination of methylphenidate in human plasma by stable isotope dilution gas chromatography/mass spectrometry. J Mass Spectrom. 2000; 35: 1100-1104.
7. MEDICE Arzneimittel Pütter GmbH & Co. KG. Fach-information (Summary of Product Characteristics): Medikinet retard 10 mg/20 mg. Berlin: Fachinfo-Service; 2005.
8. Midha KK, McKay G, Rawson MJ, Korchinski ED, Hubbard JW. Effects of food on the pharmacokinetics of methylphenidate. Pharm Res. 2001; 18: 1185-1189.
9. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: 24-month outcomes of treatment strategies for attention deficit/hyperactivity disorder. Pediatrics. 2004; 113: 754-761.
10. National Institute of health. National Institutes of Health consensus development conference statement: diagnosis and treatment of attention deficit/hyperactivity disorder. Hum Psychopharmacol. 2000; 12: 527-546.
11. Patrick KS, Mueller RA, Gualtieri CT, Breese GR. Pharmcokinetics and actions of methylphenidate. In: Meltzer HY (ed). Psychopharmcology: The Third Generation of Progress. New York: Raven Press; 1987. pp. 1387-1395.
12. Pentikis HS, Simmons RD, Benedict MF, Hatch SJ. Methylphenidate bioavailability in adults when an extended-release multiparticulate formulation is administered sprinkled on food or as an intact capsule. J Am Acad Child Adolesc Psychiatry. 2002; 41: 443-449.
13. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A. EU Clinical Guidelines for Hyperkinetic disorder, first update. Eur Child Adolesc Psychiatry. 2004; 13 (Suppl 1): 17-130.